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Abstract 
The cardiovascular system is under the control of the circadian clock, and disturbed circadian 
rhythms can induce cardiovascular pathologies. This cyclic regulation is probably brought 
about by the circadian expression of genes encoding enzymes and regulators involved in 
cardiovascular functions. We have previously shown that the rhythmic transcription of output 
genes is, in part, regulated by the clock-controlled PAR bZip transcription factors DBP 
(albumin D-element Binding Protein), HLF (Hepatic Leukemia Factor), and TEF (Thyrotroph 
Embryonic Factor). The simultaneous deletion of all three PAR bZip transcription factors 
leads to increased morbidity and shortened life span. Here, we demonstrate that Dbp/Tef/Hlf 
triple knockout mice develop cardiac hypertrophy and left ventricular dysfunction associated 
with a low blood pressure. These dysfunctions are exacerbated by an abnormal response to 
this low blood pressure characterized by low aldosterone levels. The phenotype of PAR bZip 
knockout mice highlights the importance of circadian regulators in the modulation of 
cardiovascular functions. 
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Introduction 
Circadian clocks are allowing a large variety of organisms to adapt their physiology and 
behaviour to environmental changes in a proactive fashion. In mammals, most aspects of 
physiology, including the regulation of the cardiovascular system, are under the control of 
this molecular timekeeping system (13). Indeed, blood pressure and heart rate are subject to 
circadian oscillations, which can influence both the degree and the type of cardiac 
hypertrophy and remodeling when they are disturbed (2, 26). In addition, a misalignment 
between the intrinsic circadian period and the environmentally imposed rhythms can induce 
cardiovascular disease (16, 17, 19). Hence, cardiovascular failures, such as acute myocardial 
infarction, are more frequent at certain hours of the day (15, 27). Centrally mediated 
autonomic or neurohumoral activation plays an important role in the development of these 
circadian variations. However, tissue- or cell-autonomous pathways imposed by local 
peripheral clocks may also contribute to these rhythmic patterns. 
In mammals, the master pacemaker resides in the suprachiasmatic nuclei (SCN) of the 
hypothalamus. SCN neurons, whose circadian phase is daily reset by light-dark cycles, 
synchronize peripheral circadian clocks through both synaptic connections and humoral 
signals (11, 21). Nevertheless, feeding-fasting rhythms, which are themselves imposed by 
SCN-driven rest-activity cycles, are the dominant Zeitgebers for most peripheral organs, 
including heart, liver, and kidney (3, 20). At the molecular level, the circadian clockwork 
circuitry is thought to be based on transcriptional-translational negative feedback loops, 
involving the transcriptional activators BMAL1 and its heterodimerization partners CLOCK 
and NPAS2, and the negatively acting proteins PERIOD 1 (PER1), PERIOD 2 (PER2), 
CRYPTOCHROME 1 (CRY1), and CRYPTOCHROME 2 (CRY2) (12). These core clock 
components regulate a large number of output genes, either directly or by driving the 
rhythmic expression of downstream transcription factors, such as DBP (albumin D-site-
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Binding Protein), HLF (Hepatic Leukemia Factor), and TEF (Thyrotroph Embryonic Factor), 
the three members of the PAR bZip (Proline and Acidic amino acid-Rich basic leucine 
Zipper) protein family (8). 
Previous studies have shown that the simultaneous loss of Dbp, Hlf, and Tef in PAR 
bZip triple knockout (KO) mice leads to an increased morbidity and severely shortens the life 
span of these animals (10). Thus, about 50% of young adults succumb to spontaneous and 
sound-induced seizures (10). After three months of age, the surviving animals become more 
resilient to epileptic attacks, but they display symptoms of accelerated ageing. At least in 
part, a deficiency in xenobiotic detoxification might account for these symptoms, as PAR 
bZip transcription factors are important regulators of genes implicated in this process (9). 
Here, we present evidence that these mice also display a cardiac hypertrophy. To gain insight 
into the potential roles of PAR bZip transcription factors in cardiovascular functions, we 
investigated cardiovascular phenotypes of Dbp-/-/Hlf -/-/Tef -/- triple KO mice (henceforth 
called KO mice) in greater detail. 
 
 
Materials and Methods 
Animals 
PAR bZip triple knockout mice have been previously described (10). Four to eight month-old 
male mice, 72 in total, were used in all studies. Four different groups of mice were used in 
the different protocols as follows: 30 mice (10 of each genotype) were used for the analysis 
of ENaC activity and urinary electrolytes, left ventricular hemodynamic measurements, and 
plasma aldosterone concentrations; 15 mice (5 of each genotype) were used for the telemetric 
measurements of blood pressure and heart rate; 15 mice (5 of each genotype) were used for 
determining the dose-response to 1-receptor blockade; and 12 mice (6 of each genotype) 
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were used for measuring the response of ENaC activity to exogenous aldosterone. 
Experiments on live animals were approved by an institutional committee for the humane use 
of animals. All mice were housed in a temperature- and humidity-controlled room with an 
automatic 12 h light/12 h dark cycle and fed ad libitum with a regular chow diet containing 3 
mg Na+/g of food.  
Cardiovascular and renal parameters: 
Blood pressure (BP) was measured by telemetry. For this purpose, mice were first 
anaesthetized with 1-2% halothane mixed with oxygen. A catheter tip of TA11PA-C10 BP 
transmitter (Data Sciences International, St. Paul, MN, USA) was inserted into the aortic arch 
via left carotid artery. The body of the transmitter was implanted subcutaneously on the right 
side of the chest. After a 2-week recovery period, BP and heart rate (HR) of the free moving 
animals were monitored continuously with a scheduled sampling (10 seconds every 5 
minutes) for two weeks, using a computerized data-acquisition system (Dataquest ART 
software version 3.1) provided by Data Science International. 
Cardiac haemodynamic parameters were also measured in conscious mice, using a fluid-filled 
catheter with high frequency response and high fidelity enabling to monitor left ventricular 
hemodynamic parameters in non-anesthetized mice, as described previously (22). 
The activity of the epithelial sodium channel (ENaC) in the distal colon was measured in vivo 
as the amiloride-sensitive rectal potential difference (ami-s-PD or ΔPDamil) as described 
previously (23). To test whether the ENaC channel was normally induced by aldosterone, 
rectal PDamil was measured before and 6 hours after administration of aldosterone (6 mg /kg, 
i.p). 
Urine samples were collected into 1.5 mL Eppendorf tubes for 4 h at the same Zeitgeber time 
as rectal PD measurements were taken. Serum and urinary Na+, K+, and creatinine 
 
 6
concentrations were analyzed by flame photometry (model 943, Instrumentation Laboratory). 
Plasma aldosterone was measured by conventional radioimmunoassays. 
The activity of the sympathetic nervous system in these mice was evaluated by measuring the 
cardiac and heart rate response to selective 1-adrenoreceptor blockade using the beta-blocker 
atenolol. Atenolol was administered intravenously at increasing doses (3, 10, and 60 mg/kg), 
and BP, heart rate, and left ventricular function was monitored in conscious mice. 
Statistical analysis 
All physiological parameters are presented as mean ± SEM. Statistical comparisons between 
groups were performed by a 1-way ANOVA, followed by a Newman-Keuls test. P≤0.05 was 
considered the minimal level of significance. 
 
Results 
PAR bZip deficient mice develop cardiac hypertrophy and left ventricular dysfunction 
Examination of PAR bZip KO mice revealed a cardiac hypertrophy. Indeed, as compared to wild-type 
(WT) and heterozygous (HZ) animals, the heart weight over body weight (HW/BW) ratio was 
significantly increased in KO mice (Figure 1A), even if the histopathological analysis revealed no 
abnormality (data not shown). These animals also displayed characteristics of both systolic and 
diastolic dysfunction in the left ventricle, including a lower left ventricular systolic pressure (LVSP), 
an increase in left ventricular end-diastolic pressure (LVEDP), a prolongation of the left ventricular 
relaxation time constant (Weiss Tau), and a significant decrease in the absolute values of LVdP/dtmin 
and LVdP/dtmax (Figure 1C-F). Moreover, the lung weight (LW) to BW ratio was increased in KO 
mice, indicating increased pulmonary water content due to left ventricular dysfunction (Figure 1B). 
 
PAR bZip deficient mice display altered blood pressure and heart rate 
Cardiac hypertrophy has multiple causes, including arterial hypertension. We thus measured 
by telemetry the blood pressure (BP) and heart rate (HR) of these mice over several days to 
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analyze the diurnal variations of these parameters. As shown in Figure 2, diurnal rhythms of 
BP and HR were maintained in KO as well as in HZ mice, with dipping during the day then 
rising during the night. However, BP was significantly lower and HR higher in KO mice than 
in WT mice. HZ mice had an intermediate phenotype, with an increased heart rate and a 
slightly (but not statistically significant) lower BP than WT mice.  
 
PAR bZip deficient mice have an increased activity of the sympathetic nervous system 
As mentioned above, both KO and HZ mice had an increased heart rate when compared to 
WT mice. This may reflect an increased sympathetic activity in order to maintain cardiac 
output. To test this hypothesis, we investigated the activity of the sympathetic nervous system 
in these mice by measuring the cardiac and heart rate response to selective 1-adrenoreceptor 
blockade using the drug atenolol. Atenolol was administered intravenously at increasing 
doses, and BP, HR, and left ventricular function were monitored in conscious mice by 
invasive catheterization. As shown in Figure 3, the responsiveness to beta-receptor blockade 
was significantly enhanced for all parameters in KO mice, with an intermediate response in 
HZ animals. This result confirmed that KO mice, and to a lesser extend HZ mice, presented 
an increased sympathetic activity. This led to an accelerated HR, probably to compensate for 
the low cardiac output. 
 
PAR bZip deficient mice display an inappropriate response to low blood pressure 
In response to a decreased blood pressure, the kidney normally increases salt re-absorption. 
We thus evaluated salt absorption by measuring the difference in salt excretion with the urine 
over several days. Urine samples were collected in the morning (ZT0 to ZT4; ZT is Zeitgeber 
Time; ZT0 and ZT12, are the times when light is turned on and off, respectively) and during 
the night (ZT12 to ZT16). Urinary volumes were significantly greater in KO than in HZ and 
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WT mice, like water and sodium (food) intakes (Figure 4A-C). However, body weight and 
serum sodium and potassium concentrations were comparable among the three groups (data 
not shown). While urinary excretion of creatinine was similar in the three groups of mice, 
sodium excretion, expressed as sodium to creatinine ratio (Na/Cre), and, to a lesser extent, 
potassium excretion (K/Cre) were higher in KO than in HZ and WT mice over the course of 
the day (Figure 4D-F). This increased sodium excretion was probably caused by the 
augmented salt absorption. However, contrary to what would have been predicted, salt re-
absorption was not increased in these mice as a result of low blood pressure. 
Indeed, we expected an increase in salt re-absorption through the activation of the 
amiloride-sensitive epithelial sodium channel (ENaC), the main regulator of salt re-
absorption located in the distal nephron of the kidney. This is normally achieved by rising the 
activity of the renin-angiotensin-aldosterone system. The absence of increased salt re-
absorption in the mutant mice could therefore be the consequence of an inappropriate 
activation of the renin-angiotensin-aldosterone system. The triple KO mice have a mixed 
C57Bl/6-129sv-129Ola genetic background and their haploid genome harbors two Renin 
genes. As described previously, the presence of the Renin2 gene causes a 100-fold increase in 
the plasma renin concentration, which masked the usual negative feedback control on renin 
activity (24). However, when we measured Renin gene mRNA accumulation in the kidney of 
KO mice we observed a 1.6 fold reduction in Renin1 mRNA accumulation in response to low 
blood pressure, rather than the expected increase (data not shown). We also wished to 
evaluate the adaptation of the aldosterone system to low blood pressure in KO mice. To this 
end we determined the acute response of the ENaC channel to exogenous aldosterone in the 
distal colon. This tissue is a secondary site of ENaC expression that is more accessible than 
nephrons and permits the direct determination of the channel activity by monitoring the net 
change in rectal ami-s-PD. As shown in Figure 5A, the ENaC activity was not significantly 
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different in KO and WT mice in response to exogenous aldosterone, suggesting that the 
intrinsic channel responsiveness was not affected in PAR bZip KO mice. However, plasma 
aldosterone levels were reduced by approximately 40 % in KO mice compared to WT and 
HZ mice (Figure 5B), reflecting an inappropriate response to low blood pressure. 
To investigate the possible consequence of the low aldosterone levels on the diurnal 
ENaC activity in vivo, we monitored the amiloride-sensitive potential difference (ami-s-PD) 
in the distal colon. The rectal ami-s-PD of both WT and HZ mice followed a clear diurnal 
rhythm, with a low activity in the morning (resting phase) and a higher activity at night 
(activity phase) (Figure 6). In contrast, the diurnal rhythm of ami-s-PD was completely 
abolished in PAR bZip deficient mice, suggesting an impaired rhythmic activity of the 
amiloride sensitive channel and confirming the inappropriate response to low blood pressure. 
 
 
Discussion 
The PAR bZip transcription factors DBP, HLF, and TEF serve as mediators in translating 
daily oscillations generated by the molecular clockwork circuitry into overt circadian rhythms 
in gene expression and physiology. The observation that KO mice display cardiac 
hypertrophy motivated us to examine their role in the cardiovascular system. Our results 
demonstrated that the deletion of PAR bZip transcription factors had a major impact on 
cardiac and renal functions, leading to the development of cardiac hypertrophy, left 
ventricular dysfunction, and increased sympathetic activity. Unexpectedly these symptoms 
were associated with low blood pressure and low aldosterone levels, possibly caused by an 
inappropriate response to this state. 
As mentioned previously, a low BP and an increased HR could also be a manifestation 
of a cardiac dysfunction. Despite the low BP, KO mice had a clear left ventricular 
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hypertrophy. Moreover, KO mice displayed several hemodynamic characteristics of heart 
failure, including a lower left ventricular systolic pressure, an increase in left ventricular end-
diastolic pressure, a prolongation of the left ventricular relaxation time constant (Weiss Tau), 
and a significant decrease in the absolute values of LVdP/dtmin and LVdP/dtmax. In addition, 
the lung weight to body weight ratio was enlarged, suggesting an increased pulmonary water 
content. Moreover, KO mice exhibited an enhanced hemodynamic response to acute -
receptor blockade when compared to WT or HZ mice, demonstrating an increased activity of 
the sympathetic nervous system commonly observed early in the course of diastolic 
dysfunction (6). These results indicated that the deletion of PAR bZip transcription factors 
had a major impact on cardiac function, which appeared to be gene dosage dependent. In fact 
HZ mice had an intermediate phenotype with some signs of compensated diastolic 
dysfunction. 
The normal response to low blood pressure suggested an increase in aldosterone 
synthesis. However, this was not the case in PAR bZip KO mice, as these animals displayed a 
reduced plasma aldosterone level. Aldosterone synthesis is achieved by the processing of 
corticosterone by aldosterone synthase. Interestingly, it had been shown previously that corticosterone 
synthesis is controlled by the circadian clock, which regulates, directly or indirectly, the expression of 
enzymes involved in corticosterone synthesis in the adrenal gland (18). In addition, it has recently 
been demonstrated that the circadian clock, through the PAR bZip transcription factors, also 
modulates the expression of HSD3B6, an enzyme directly involved in aldosterone synthesis in the 
adrenal gland (5). It is thus conceivable that the PAR bZip transcription factors could be implicated in 
this process, potentially explaining the lower levels of aldosterone in KO mice. 
PAR bZip deficient mice also exhibited an increased urinary sodium and potassium 
excretion. It is difficult to conclude in a decisive manner whether the increased urinary 
sodium excretion was a primary consequence of PAR bZip loss-of-function or just a result of 
increased sodium intake. To address this question, other manifestations of an impaired renal 
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regulation of sodium excretion were explored. The amiloride-sensitive epithelial sodium 
channel (ENaC) located in the distal nephron and distal colon is responsible for the fine 
regulation of sodium excretion (14). In contrast to WT and HZ mice, ENaC activity in the 
distal colon was very low in KO mice. Moreover, the daily rhythm of ami-s-PD was 
completely abolished in KO mice. The low activity and the absence of a clear diurnal rhythm 
of ENaC could not be explained by a higher salt intake, as previous experiments conducted in 
mice receiving a very high sodium intake (16 mg Na+/g of food) have shown that the rhythm 
is maintained even at lower levels of ENaC activity (23). This suggested that the low 
aldosterone synthesis in PARb Zip KO mice contributed to the inappropriate response to low 
blood pressure. 
The lower BP of KO mice was associated with an increased HR, which likely reflected 
a compensatory mechanism to maintain cardiac output through the persistent activation of the 
sympathetic nervous system, which could lead to cardiac hypertrophy. The cardiac 
dysfunction could therefore be the consequence of the persistently high HR (7). Indeed, a 
relative hypovolemia due for example to a sodium loss could explain the cardiac hypertrophy, 
and the renal sodium excretion was, in fact, significantly higher in KO mice than in WT 
animals, despite of the low BP. However, it is also conceivable that the loss of PAR bZip 
transcription factors engendered a primary cardiac dysfunction. While left ventricular 
dysfunction was the main cause of the low BP, one would have expected a lower sodium 
excretion in KO mice, due to the renal hypoperfusion associated with a low cardiac output. 
However, in that case the renin-angiotensin-aldosterone system should have been activated, 
which was clearly not observed in PAR bZip deficient mice. This suggested that the 
phenotype was probably caused by the combination of a perturbed heart function and an 
inappropriate response of the renin-angiotensin-aldosterone system to low blood pressure, 
which contributed to a defective salt re-absorption in the kidney. This observation supported 
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the hypothesis of a perturbed kidney function, which could have been caused by a 
deregulated expression of genes involved in BP regulation in these mice, as reported by 
Zuber A.M. et al. (28). 
Clock-controlled transcription factors, such as the PAR bZip proteins, govern the 
rhythmic expression of genes and hence contribute to the regulation of several physiological 
rhythms (8). Interestingly, in contrast to the observations made in mice with a disruption of 
the gene encoding BMAL1, the master regulator of the molecular circadian clock (1), our 
results showed that the circadian pattern of blood pressure was maintained in KO mice. 
Nevertheless, BP was significantly lower in KO mice (and to a lesser degree in HZ mice), an 
observation indicating that important determinants of the regulation of blood pressure were 
affected by the loss of the PAR bZip transcription factors. Interestingly, a lower BP with a 
conserved diurnal rhythm was also found in Npas2 (1) and Clock (28) KO mice, the genes 
specifying the heterodimerization partner of BMAL1. These two animal models, similar to 
PAR bZip KO mice, display a normal diurnal rhythm of locomotor activity with a decreased 
expression of the output genes regulated by the clock (4). The fact that these three mouse 
models exhibit a similar BP phenotype suggests that the cyclic expression of relevant clock 
outputs genes, rather than a rhythmic behavior, is required to regulate the level of BP. 
Unfortunately, the cardiac phenotypes of these mice have not yet been studied in detail. 
 
Perspectives and Significance 
In humans, a recent study, aimed at inducing a circadian misalignment in ten adults by 
submitting them to 28 hours “days”, showed that already after eight days some subjects 
displayed decreased leptin levels, increased blood glucose concentrations (despite increased 
insulin levels), phase-inverted daily cortisol rhythms, increased mean arterial pressure, and 
reduced sleep efficiency (19). Moreover, two different haplotypes of the BMal1 gene have 
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been linked to a susceptibility to hypertension and type 2 diabetes (25). Given the 
extraordinary phylogenetic conservation of the BMAL1-regulated PAR bZip transcription 
factors (8, 9), we consider likely that these circadian regulators could also be involved in the 
modulation of cardiovascular functions in humans. 
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Figure Legends 
 
Figure 1. Effect of PAR bZip gene disruption on cardiac function 
A) Heart weight to body weight ratio (HW/BW) as an index of cardiac hypertrophy in PAR 
bZip KO (black), HZ (grey) and WT (white) mice. n=14-16 mice per group. 
B) Lung weight to body weight ratio (LW/BW) an index of heart failure. n= 8 mice per 
group. 
C) Left ventricular end diastolic pressure (LVEDP), a sign of cardiac dysfunction, is 
significantly elevated in the KO. 
D) Time constant of isovolumic relaxation (Weiss Tau), an index of cardiac relaxation time, 
is significantly prolonged in the KO. 
E) LVdP/dtmin and LVdP/dtmax assessing left ventricular contractility, systolic and diastolic 
blood pressure, respectively, are significantly decreased in both KO and HZ mice. 
F) Left ventricular systolic pressure (LVSP) is markedly decreased in the KO mice. 
n=6-8 mice per group for hemodynamic measurements. 
Values are means ± SEM, * p≤0.05, ** p≤0.01 KO vs. WT, and HZ. # p≤0.05 HZ vs WT, 
one-way ANOVA. 
 
Figure 2. Influence of the deletion of the PAR bZip genes on daily mean blood pressure 
(MBP) and heart rate (HR). 
A) Individual tracing of MBP and HR in PAR bZip knockout (KO), heterozygous (HZ), and 
wild-type (WT) mice during 48 hours. 
B) 24-hour telemetric MBP and HR in PAR bZip KO (■), HZ (▲) and WT (□) mice. Each 
time point represents the average of 3 hours of monitored data. MBP and HR in the KO mice 
have the same circadian rhythm as WT and HZ. However, MBP of KO is significantly lower 
(upper panel) and HR higher (lower panel) over the course of the day compared to the WT. 
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HZ have an intermediate phenotype. X-axis, black Box indicates the dark period and white 
box indicates the light period. Values are means ± S.E.M., n=5 mice per group. * p≤0.05, ** 
p≤0.01, KO vs. WT. 
 
Figure 3: Exacerbated response to 1-receptor blockade in PAR bZip KO mice 
A) HR response (expressed at the % of difference of HR) to atenolol in PAR bZip KO mice 
(■), HZ (▲) and WT (□) mice. 
B) Difference in left ventricular systolic pressure response induced by atenolol injection. 
C and D) Changes in LVdP/dtmax and LVdP/dtmin in response to atenolol. 
Values are mean ± SEM, n=5 mice per group. * p≤0.05, ** p≤0.01, one-way ANOVA. 
 
Figure 4. Influence of the deletion of the PAR bZip genes on sodium and fluid intake, and on 
urinary electrolyte excretion. 
A) Influence of PAR bZip gene knockout on urinary volumes in mice. Urine was collected in 
the morning (ZT0-ZT4) and in the night (ZT12-ZT16), respectively. 
B) 24-hour recordings of water intake. 
C) 24-hour recordings of sodium intake. Values are based on the intake of food containing 3 
mg Na+/g. 
D) Urinary creatinine excretion in KO, HZ, and WT mice. 
E) Urinary sodium excretion expressed as urinary sodium to creatinine ratio. 
F) Urinary potassium excretion expressed as urinary sodium to creatinine ratio. 
Values are means ± SEM, n=10 mice per group. * p≤0.05, ** p≤0.01, *** p≤0.001 KO vs. 
HZ and WT, one-way ANOVA. X-axis, black boxes indicates the dark period (from 19:00 to 
23:00 or ZT 12-16), and white boxes indicates the light period (ZT0-ZT4). 
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Figure 5. Response to aldosterone and aldosterone synthesis in PAR bZip KO mice 
A) Response of ENaC activity to exogenous aldosterone. The rectal PDamil was measured 
before and 6 hours after the administration of aldosterone (6 mg /kg, i.p). No significant 
difference is observed between KO and WT. Values are means ± SEM, n=6 per group. 
B). Plasma aldosterone levels in PAR bZip KO (black), HZ (grey) and WT (white) mice. 
Plasma aldosterone levels are significant lower in the KO mice. Values are means ± SEM, 
n=6-8 mice per group, * p≤0.05 KO vs. HZ or vs. WT, one-way ANOVA. 
 
Figure 6. Activity of the epithelial sodium channel (ENaC) in distal colon. 
The amiloride-sensitive potential difference (ami-s-PD or PDamil) in colon as an index of 
ENaC activity was measured daily in the morning and the night for 3 days. The amplitude of 
circadian oscillations of ami-s-PD are comparable in WT (□) and HZ (▲), but completely 
abolished in the KO (■). Values are means ± SEM, n=6-8 per group. * p≤0.001 KO vs. HZ 
and WT, one-way ANOVA.  
X-axis, black boxes indicates the dark period (from 19:00 to 23:00 or ZT 12-16), and white 
boxes indicates the light period (ZT0-ZT4). 
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